Natalizumab discontinuation: an increasingly tricky proposition
- PMID: 22054207
- DOI: 10.1111/j.1468-1331.2011.03574.x
Natalizumab discontinuation: an increasingly tricky proposition
Comment on
-
Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study.Eur J Neurol. 2012 May;19(5):783-7. doi: 10.1111/j.1468-1331.2011.03577.x. Epub 2011 Nov 7. Eur J Neurol. 2012. PMID: 22054236
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
